Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-05 Carulli Michael Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +240,000 240,000
2025-07-01 Carulli Michael Chief Financial Officer Sale −28,249 $1.06 $30K 60,146
2025-03-03 Carulli Michael Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +265,000 265,000
2024-09-11 Carulli Michael Chief Financial Officer Sale −2,891 $1.50 $4K 88,395
2024-08-13 Carulli Michael Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −13,605 0
2024-08-13 Carulli Michael Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −27,200 0
2024-08-13 Carulli Michael Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +40,805 40,805
2024-08-13 Carulli Michael Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −75,000 75,000
2024-08-13 Carulli Michael Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2024-01-18 Carulli Michael Chief Financial Officer Grant or award +82,220 91,286
2024-01-18 Carulli Michael Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +204,630 204,630

Page 1 of 1 · 11 trades